Lansdale, PA, United States of America

Tom Dziubla


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tom Dziubla: Innovator in Antioxidant Polymer Nanocarriers

Introduction

Tom Dziubla is a prominent inventor based in Lansdale, PA (US). He has made significant contributions to the field of polymer nanotechnology, particularly in the development of methods for encapsulating active proteins. His innovative work focuses on enhancing the therapeutic applications of enzymes through advanced encapsulation techniques.

Latest Patents

Dziubla holds a patent for "Antioxidant polymer nanocarriers for use in preventing oxidative injury." This invention presents a method for encapsulating active proteins in a polymeric nanocarrier. The method employs homogenization at subzero temperatures, which helps retain enzyme activity. The encapsulation process protects enzymes from protease degradation and increases their therapeutic half-life. Notably, the polymeric nanoparticles developed through this method are permeable to enzyme substrates, allowing the encapsulated enzymes to exert their effects without needing to be released from the nanocarrier.

Career Highlights

Tom Dziubla is affiliated with the University of Pennsylvania, where he continues to advance research in the field of nanotechnology. His work has implications for various therapeutic applications, particularly in protecting against oxidative stress and detoxifying xenobiotics.

Collaborations

Dziubla collaborates with Vladimir R Muzykantov, a fellow researcher in the field. Their partnership enhances the potential for innovative solutions in the realm of enzyme therapy and nanotechnology.

Conclusion

Tom Dziubla's contributions to the field of antioxidant polymer nanocarriers demonstrate his commitment to advancing medical technology. His innovative methods have the potential to significantly impact therapeutic practices in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…